572.4500 5.30 (0.93%)
NSE Jan 07, 2026 15:31 PM
Volume: 60,355
 

572.45
0.93%
Axis Direct
We expect Gross Margins to be impacted due to an increase in revenue share from non-regulated markets and an increase in raw material prices going onwards. Hence, we recommend a HOLD rating on the stock with a target price of INR 1,670 (PE 20x for FY23EPS).
Solara Active Pharma Sciences Ltd. is trading above its 50 day SMA of 567.0
More from Solara Active Pharma Sciences Ltd.
Recommended